11.28
0.11 (0.98%)
| Previous Close | 11.17 |
| Open | 11.20 |
| Volume | 7,890,484 |
| Avg. Volume (3M) | 10,605,456 |
| Market Cap | 7,690,871,296 |
| Price / Earnings (Forward) | 12.02 |
| Price / Sales | 1.19 |
| Price / Book | 1.40 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2025 |
| Profit Margin | 10.70% |
| Operating Margin (TTM) | 8.21% |
| Diluted EPS (TTM) | 1.04 |
| Quarterly Revenue Growth (YOY) | -5.90% |
| Quarterly Earnings Growth (YOY) | 6.80% |
| Total Debt/Equity (MRQ) | 67.34% |
| Current Ratio (MRQ) | 1.12 |
| Operating Cash Flow (TTM) | 808.50 M |
| Levered Free Cash Flow (TTM) | 751.08 M |
| Return on Assets (TTM) | 3.53% |
| Return on Equity (TTM) | 12.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.13 |
|
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 103.17% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| New Mountain Capital, L.L.C. | 30 Sep 2025 | 14,000,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 17.00 (Baird, 50.71%) | Buy |
| Median | 13.00 (15.25%) | |
| Low | 9.00 (Jefferies, -20.21%) | Sell |
| Average | 13.33 (18.17%) | |
| Total | 3 Buy, 2 Hold, 1 Sell | |
| Avg. Price @ Call | 12.37 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Jefferies | 17 Dec 2025 | 9.00 (-20.21%) | Sell | 11.10 |
| Barclays | 30 Oct 2025 | 12.00 (6.38%) | Hold | 11.05 |
| 02 Oct 2025 | 15.00 (32.98%) | Buy | 13.77 | |
| Evercore ISI Group | 30 Oct 2025 | 14.00 (24.11%) | Buy | 11.05 |
| JP Morgan | 30 Oct 2025 | 12.00 (6.38%) | Hold | 11.05 |
| Baird | 24 Oct 2025 | 17.00 (50.71%) | Buy | 15.40 |
| Raymond James | 16 Oct 2025 | 16.00 (41.84%) | Buy | 14.57 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |